Cargando…

Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012–2013 Medical Expenditures Panel Survey

BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD) causes most deaths in the United States and accounts for the highest healthcare spending. The association between the modifiable risk factors (MRFs) of ASCVD and pharmaceutical expenditures are largely unknown. METHODS AND RESULTS: We examin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salami, Joseph A., Valero‐Elizondo, Javier, Ogunmoroti, Oluseye, Spatz, Erica S., Rana, Jamal S., Virani, Salim S., Blankstein, Ron, Younus, Adnan, Arrieta, Alejandro, Blaha, Michael J., Veledar, Emir, Nasir, Khurram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669151/ https://www.ncbi.nlm.nih.gov/pubmed/28600400 http://dx.doi.org/10.1161/JAHA.116.004996

Ejemplares similares

Economic Impact of Moderate‐Vigorous Physical Activity Among Those With and Without Established Cardiovascular Disease: 2012 Medical Expenditure Panel Survey
por: Valero‐Elizondo, Javier, et al.
Publicado: (2016)

Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012–2013 Medical Expenditure Panel Survey
por: Singh, Jai, et al.
Publicado: (2018)

National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel Survey
por: Salami, Joseph A., et al.
Publicado: (2018)

Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006–2015
por: Okunrintemi, Victor, et al.
Publicado: (2021)

Life's Simple 7 and Incident Heart Failure: The Multi‐Ethnic Study of Atherosclerosis
por: Ogunmoroti, Oluseye, et al.
Publicado: (2017)

Association Between Life's Simple 7 and Noncardiovascular Disease: The Multi‐Ethnic Study of Atherosclerosis
por: Ogunmoroti, Oluseye, et al.
Publicado: (2016)

Gender Differences in Patient‐Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease
por: Okunrintemi, Victor, et al.
Publicado: (2018)

Cumulative Burden of Financial Hardship From Medical Bills Across the Spectrum of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease Among Non‐Elderly Adults in the United States
por: Mszar, Reed, et al.
Publicado: (2020)

Age-specific differences in patient reported outcomes among adults with atherosclerotic cardiovascular disease: Medical expenditure panel survey 2006–2015
por: Okunrintemi, Victor, et al.
Publicado: (2020)

Estimates of Mortality Benefit From Ideal Cardiovascular Health Metrics: A Dose Response Meta‐Analysis
por: Aneni, Ehimen C., et al.
Publicado: (2017)

Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States
por: Mahajan, Shiwani, et al.
Publicado: (2021)

Unfavorable social determinants of health are associated with higher burden of financial toxicity among patients with atherosclerotic cardiovascular disease in the US: findings from the National Health Interview Survey
por: Valero-Elizondo, Javier, et al.
Publicado: (2022)

Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease
por: Agrawal, Tanushree, et al.
Publicado: (2021)

Association of cardiovascular risk profile with healthcare expenditure and resource utilization in chronic obstructive pulmonary disease, with and without atherosclerotic cardiovascular disease
por: Jafar, Zain, et al.
Publicado: (2020)

Association of Subjective and Objective Sleep Duration as well as Sleep Quality with Non-Invasive Markers of Sub-Clinical Cardiovascular Disease (CVD): A Systematic Review
por: Aziz, Muhammad, et al.
Publicado: (2017)

Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults—A population-level analysis in the national health interview survey
por: Nasir, Khurram, et al.
Publicado: (2022)

Nondietary Cardiovascular Health Metrics With Patient Experience and Loss of Productivity Among US Adults Without Cardiovascular Disease: The Medical Expenditure Panel Survey 2006 to 2015
por: Tibuakuu, Martin, et al.
Publicado: (2020)

Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives
por: Arrieta, Alejandro, et al.
Publicado: (2017)

EU pharmaceutical expenditure forecast
por: Urbinati, Duccio, et al.
Publicado: (2014)

Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions
por: Khera, Rohan, et al.
Publicado: (2020)

Novel methodology for pharmaceutical expenditure forecast
por: Vataire, Anne-Lise, et al.
Publicado: (2014)

Variation and Disparities in Awareness of Myocardial Infarction Symptoms Among Adults in the United States
por: Mahajan, Shiwani, et al.
Publicado: (2019)

Lipoprotein Sub-Fractions by Ion-Mobility Analysis and Its Association with Subclinical Coronary Atherosclerosis in High-Risk Individuals
por: Aneni, Ehimen C, et al.
Publicado: (2019)

Out‐of‐Pocket Annual Health Expenditures and Financial Toxicity From Healthcare Costs in Patients With Heart Failure in the United States
por: Wang, Stephen Y., et al.
Publicado: (2021)

Trends and Costs Associated With Suboptimal Physical Activity Among US Women With Cardiovascular Disease
por: Okunrintemi, Victor, et al.
Publicado: (2019)

Differences in Medical Expenditures for Men and Women with Diabetes in the Medical Expenditure Panel Survey, 2008–2016
por: Williams, Joni S., et al.
Publicado: (2020)

Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States
por: Valero-Elizondo, Javier, et al.
Publicado: (2021)

Pharmaceutical Expenditure and Burden of Non-communicable Diseases in Serbia
por: Kovacevic, Aleksandra, et al.
Publicado: (2016)

Heterogeneity in cardio-metabolic risk factors and atherosclerotic cardiovascular disease among Asian groups in the United States
por: Satish, Priyanka, et al.
Publicado: (2021)

Trends of medical expenditures and quality of life in US adults with diabetes: the medical expenditure panel survey, 2002–2011
por: Campbell, Jennifer A., et al.
Publicado: (2017)

Association of cardiovascular risk factor profile and financial hardship from medical bills among non-elderly adults in the United States
por: Grandhi, Gowtham R., et al.
Publicado: (2020)

Low educational attainment is associated with higher all-cause and cardiovascular mortality in the United States adult population
por: Khan, Najah, et al.
Publicado: (2023)

Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?
por: Farfan-Portet, María-Isabel, et al.
Publicado: (2013)

Estimating the Fiscal Effects of Public Pharmaceutical Expenditure Reduction in Greece
por: Souliotis, Kyriakos, et al.
Publicado: (2015)

Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran
por: Zarei, Leila, et al.
Publicado: (2022)

Trends in National Pharmaceutical Expenditure in Korea during 2011 - 2020
por: Kim, Yujeong, et al.
Publicado: (2023)

Health Care Expenditures for Adults With Multiple Treated Chronic Conditions: Estimates From the Medical Expenditure Panel Survey, 2009
por: Machlin, Steven R., et al.
Publicado: (2013)

The impact of arthritis and joint pain on individual healthcare expenditures: findings from the Medical Expenditure Panel Survey (MEPS), 2011
por: Williams, Edith M., et al.
Publicado: (2017)

Sex differences in healthcare expenditures among adults with diabetes: evidence from the medical expenditure panel survey, 2002–2011
por: Williams, Joni S., et al.
Publicado: (2017)

Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement
por: Bhugra, Priyanka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n8vr3nklb4f5qmknkrp0gn5s88